“…CS patients frequently exhibit musculoskeletal abnormalities, such as kyphosis, contracture and osteoporosis (Hishiya and Watanabe, 2004;Karikkineth et al, 2017). MSCs are multipotent mesodermal cells that can differentiate into a variety of mesodermal cell types, including osteoblasts, chondrocytes, and adipocytes, which serve as a good cell model for investigating the accelerated degeneration of mesodermal tissues caused by genetic mutations (Liu et al, 2014;Zhang et al, 2015Zhang et al, , 2019Kubben et al, 2016;Li et al, 2016;Pan et al, 2016;Geng et al, 2018;Wang et al, 2018b;Wu et al, 2018;Yan et al, 2019). Therefore, we first differentiated CS-iPSCs and GC-iPSCs into MSCs to investigate whether ERCC6 mutations could result in accelerated attrition of the MSC pool.…”